<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67300">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02128139</url>
  </required_header>
  <id_info>
    <org_study_id>EndoDev</org_study_id>
    <secondary_id>Cardiology and Development</secondary_id>
    <nct_id>NCT02128139</nct_id>
  </id_info>
  <brief_title>Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study</brief_title>
  <acronym>EndoDev</acronym>
  <official_title>Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Mozambique</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>War Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oxford University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction. Comprehensive data on infective endocarditis in developing countries are
      scarce.

      Objectives: Description of the characteristics (clinical and microbiological) and assessment
      of the outcomes of infective endocarditis in low-income countries.

      Methods : Prospective, Observational, Multicentre study. Inclusion criteria: patients aged
      over 1 year fulfilling the modified Duke criteria for infective endocarditis.

      Exclusion criteria: patient included during a previous infective endocarditis episode.

      Outcomes measures: Mortality at 6 months follow-up; mortality at 1 month follow-up; access
      to antibiotic treatment (modalities and duration), hospital length of stay and reason for
      discharge, and cardiac surgery when indicated.

      Duration: One year (June 2014- June 2015)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Mortality at 1 month follow-up</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at 6 months follow-up</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Access to cardiac surgery</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Heart surgery is not available in many low-income countries. One of the objectives is to assess whether guidelines can be applied in low-secourced settings.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Infective Endocarditis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hospital-based population.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged over 1 year diagnosed with infective endocarditis according to the
             modified Duke criteria

        Exclusion Criteria:

          -  Already included for a previous episode of infective endocarditis (i.e., relapse or
             reinfection)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mariana S Mirabel, MD</last_name>
    <phone>+33153988000</phone>
    <email>mariana.mirabel@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eloi Marijon, MD</last_name>
    <phone>+33153988000</phone>
    <email>eloi.marijon@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Joseph Kado</name>
      <address>
        <city>Suva</city>
        <country>Fiji</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <email>jkado@health.gov.fj</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Paul N. Newton</name>
      <address>
        <city>Vientiane</city>
        <country>Lao People's Democratic Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul N Newton, MD</last_name>
      <email>paul@tropmedres.ac</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beatriz Ferreira</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <email>beatriz@tvcabo.co.mz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bara Diop</name>
      <address>
        <city>Dakar</city>
        <country>Senegal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <email>ibdsb@orange.sn‬</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Abdul Kane</name>
      <address>
        <city>Dakar</city>
        <country>Senegal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <email>abdoul_kane@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emmy Okello</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <email>emmkol@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Fiji</country>
    <country>Lao People's Democratic Republic</country>
    <country>Mozambique</country>
    <country>Senegal</country>
    <country>Uganda</country>
  </location_countries>
  <link>
    <url>http://cardiology-and-development.org</url>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 30, 2014</lastchanged_date>
  <firstreceived_date>December 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infective endocarditis</keyword>
  <keyword>Developing country</keyword>
  <keyword>Global health</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Heart valve disease</keyword>
  <keyword>Bacteremia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endocarditis</mesh_term>
    <mesh_term>Endocarditis, Bacterial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
